<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36761171</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Emerging role of hypoxia-inducible factor-1&#x3b1; in inflammatory autoimmune diseases: A comprehensive review.</ArticleTitle><Pagination><StartPage>1073971</StartPage><MedlinePgn>1073971</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1073971</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.1073971</ELocationID><Abstract><AbstractText>Hypoxia-inducible factor-1&#x3b1; (HIF-1&#x3b1;) is a primary metabolic sensor, and is expressed in different immune cells, such as macrophage, dendritic cell, neutrophil, T cell, and non-immune cells, for instance, synovial fibroblast, and islet &#x3b2; cell. HIF-1&#x3b1; signaling regulates cellular metabolism, triggering the release of inflammatory cytokines and inflammatory cells proliferation. It is known that microenvironment hypoxia, vascular proliferation, and impaired immunological balance are present in autoimmune diseases. To date, HIF-1&#x3b1; is recognized to be overexpressed in several inflammatory autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis, and function of HIF-1&#x3b1; is dysregulated in these diseases. In this review, we narrate the signaling pathway of HIF-1&#x3b1; and the possible immunopathological roles of HIF-1&#x3b1; in autoimmune diseases. The collected information will provide a theoretical basis for the familiarization and development of new clinical trials and treatment based on HIF-1&#x3b1; and inflammatory autoimmune disorders in the future.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Tang, Wang, Wang, Huang and Xu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yang-Yang</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Department of Evidence-Based Medicine, Southwest Medical University, Luzhou, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Da-Cheng</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Evidence-Based Medicine, Southwest Medical University, Luzhou, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>You-Qiang</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>An-Fang</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wang-Dong</ForeName><Initials>WD</Initials><AffiliationInfo><Affiliation>Department of Evidence-Based Medicine, Southwest Medical University, Luzhou, Sichuan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051795">Hypoxia-Inducible Factor 1, alpha Subunit</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497442">HIF1A protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051795" MajorTopicYN="N">Hypoxia-Inducible Factor 1, alpha Subunit</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HIF-1&#x3b1;</Keyword><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">immune cell</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">signaling pathway</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>3</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36761171</ArticleId><ArticleId IdType="pmc">PMC9905447</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.1073971</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhao W, Wu C, Li LJ, Fan YG, Pan HF, Tao JH, et al. . RNAi silencing of HIF-1&#x3b1; ameliorates lupus development in MRL/lpr mice. Inflammation (2018) 41(5):1717&#x2013;30. doi:&#xa0;10.1007/s10753-018-0815-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-018-0815-6</ArticleId><ArticleId IdType="pmc">PMC9271359</ArticleId><ArticleId IdType="pubmed">30043119</ArticleId></ArticleIdList></Reference><Reference><Citation>Garchow B, Maque Acosta Y, Kiriakidou M. HIF-1&#x3b1; and miR-210 differential and lineage-specific expression in systemic lupus erythematosus. Mol Immunol (2021) 133:128&#x2013;34. doi:&#xa0;10.1016/j.molimm.2021.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2021.02.019</ArticleId><ArticleId IdType="pmc">PMC8026684</ArticleId><ArticleId IdType="pubmed">33657462</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang ZC, Liu Y. Hypoxia-inducible factor-1&#x3b1; and autoimmune lupus, arthritis. Inflammation (2016) 39(3):1268&#x2013;73. doi:&#xa0;10.1007/s10753-016-0337-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-016-0337-z</ArticleId><ArticleId IdType="pubmed">27032396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YI, Yi EJ, Kim YD, Lee AR, Chung J, Ha HC, et al. . Local stabilization of hypoxia-inducible factor-1&#x3b1; controls intestinal inflammation via enhanced gut barrier function and immune regulation. Front Immunol (2021) 14:609689. doi:&#xa0;10.3389/fimmu.2020.609689</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.609689</ArticleId><ArticleId IdType="pmc">PMC7840603</ArticleId><ArticleId IdType="pubmed">33519819</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem (1995) 270(3):1230&#x2013;7. doi:&#xa0;10.1074/jbc.270.3.1230</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.3.1230</ArticleId><ArticleId IdType="pubmed">7836384</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari T, Olson J, Johnson RS, Nizet V. HIF-1&#x3b1; influences myeloid cell antigen presentation and response to subcutaneous OVA vaccination. J Mol Med (Berl) (2013) 91(10):1199&#x2013;205. doi:&#xa0;10.1007/s00109-013-1052-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-013-1052-y</ArticleId><ArticleId IdType="pmc">PMC3783576</ArticleId><ArticleId IdType="pubmed">23686259</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Luo J, Xu H, Wang Y, Jiang W, Chang K, et al. . Early secreted antigenic target 6-kDa from mycobacterium tuberculosis enhanced the protective innate immunity of macrophages partially via HIF1&#x3b1;. Biochem Biophys Res Commun (2020) 522(1):26&#x2013;32. doi:&#xa0;10.1016/j.bbrc.2019.11.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.11.045</ArticleId><ArticleId IdType="pubmed">31735338</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Liu Y, Ren G, Shao Q, Gao W, Sun J, et al. . Increased expression of surface CD44 in hypoxia-DCs skews helper T cells toward a Th2 polarization. Sci Rep (2015) 1:5. doi:&#xa0;10.1038/srep13674</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13674</ArticleId><ArticleId IdType="pmc">PMC4555176</ArticleId><ArticleId IdType="pubmed">26323509</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng W, Ren Y, Feng X, Yao G, Chen W, Sun Y, et al. . Hypoxia inducible factor-1 alpha promotes mesangial cell proliferation in lupus nephritis. Am J Nephrol (2014) 40(6):507&#x2013;15. doi:&#xa0;10.1159/000369564</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369564</ArticleId><ArticleId IdType="pubmed">25531641</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, Zhang Y, Wang L, Hu J, Wen J, Xue L, et al. . Increased autophagy in fibroblast-like synoviocytes leads to immune enhancement potential in rheumatoid arthritis. Oncotarget (2017) 8(9):15420&#x2013;30. doi:&#xa0;10.18632/oncotarget.14331</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.14331</ArticleId><ArticleId IdType="pmc">PMC5362496</ArticleId><ArticleId IdType="pubmed">28053286</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao J, Liu J, Zhou M, Wang G, Xiong X, Deng Y. Hypoxia-induced interstitial transformation of microvascular endothelial cells by mediating HIF-1&#x3b1;/VEGF signaling in systemic sclerosis. PloS One (2022) 17(3):e0263369. doi:&#xa0;10.1371/journal.pone.0263369</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263369</ArticleId><ArticleId IdType="pmc">PMC8887755</ArticleId><ArticleId IdType="pubmed">35231032</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W, Long T, Li F, Peng C, Zhao S, Chen X, et al. . HIF-1&#x3b1; may promote glycolysis in psoriasis vulgaris via upregulation of CD147 and GLUT1. Zhong Nan Da Xue Xue Bao Yi Xue Ban (2021) 46(4):333&#x2013;44. doi:&#xa0;10.11817/j.issn.1672-7347</Citation><ArticleIdList><ArticleId IdType="doi">10.11817/j.issn.1672-7347</ArticleId><ArticleId IdType="pubmed">33967078</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Jiao Y, Zhang X. Immunometabolic pathways and its therapeutic implication in autoimmune diseases. Clin Rev Allergy Immunol (2021) 60(1):55&#x2013;67. doi:&#xa0;10.1007/s12016-020-08821-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-020-08821-6</ArticleId><ArticleId IdType="pubmed">33179144</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Rossignol S, Ketheesan N, Haleagrahara N. Redox-sensitive transcription factors play a significant role in the development of rheumatoid arthritis. Int Rev Immunol (2018) 37(3):129&#x2013;43. doi:&#xa0;10.1080/08830185.2017.1363198</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08830185.2017.1363198</ArticleId><ArticleId IdType="pubmed">28898138</ArticleId></ArticleIdList></Reference><Reference><Citation>Masson N, Singleton RS, Sekirnik R, Trudgian DC, Ambrose LJ, Miranda MX, et al. . The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity. EMBO Rep (2012) 13(3):251&#x2013;7. doi:&#xa0;10.1038/embor.2012.9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2012.9</ArticleId><ArticleId IdType="pmc">PMC3323130</ArticleId><ArticleId IdType="pubmed">22310300</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hl R, Zhou J, Br&#xfc;ne B. Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1alpha stabilization. Free Radic Biol Med (2006) 40(8):1430&#x2013;42. doi:&#xa0;10.1016/j.freeradbiomed</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed</ArticleId><ArticleId IdType="pubmed">16631533</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Z, Zhang X, Zhang T, Hu L, Liu R, Wang P, et al. . The ROS/GRK2/HIF-1&#x3b1;/NLRP3 pathway mediates pyroptosis of fibroblast-like synoviocytes and the regulation of monomer derivatives of paeoniflorin. Oxid Med Cell Longev (2022) 29:2022. doi:&#xa0;10.1155/2022/4566851</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/4566851</ArticleId><ArticleId IdType="pmc">PMC8817856</ArticleId><ArticleId IdType="pubmed">35132350</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Guo S, Zhu X, Qiu J, Deng G, Qiu C. Alpinetin inhibits breast cancer growth by ROS/NF-&#x3ba;B/HIF-1&#x3b1; axis. J Cell Mol Med (2020) 24(15):8430&#x2013;40. doi:&#xa0;10.1111/jcmm.15371</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15371</ArticleId><ArticleId IdType="pmc">PMC7412407</ArticleId><ArticleId IdType="pubmed">32562470</ArticleId></ArticleIdList></Reference><Reference><Citation>King D, Yeomanson D, Bryant HE. PI3King the lock: Targeting the PI3K/Akt/mTOR pathway as a novel therapeutic strategy in neuroblastoma. J Pediatr Hematol Oncol (2015) 37(4):245&#x2013;51. doi:&#xa0;10.1097/MPH.0000000000000329</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPH.0000000000000329</ArticleId><ArticleId IdType="pubmed">25811750</ArticleId></ArticleIdList></Reference><Reference><Citation>Park ST, Kim BR, Park SH, Lee JH, Lee EJ, Lee SH, et al. . Suppression of VEGF expression through interruption of the HIF&#x2212;1&#x3b1; and akt signaling cascade modulates the anti&#x2212;angiogenic activity of DAPK in ovarian carcinoma cells. Oncol Rep (2014) 31(2):1021&#x2013;9. doi:&#xa0;10.3892/or.2013.2928</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2013.2928</ArticleId><ArticleId IdType="pubmed">24337450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Xue K, Li Q, Liu Z, Zhu Z, Chen J, et al. . Cyclin-dependent kinase 7 promotes Th17/Th1 cell differentiation in psoriasis by modulating glycolytic metabolism. J Invest Dermatol (2021) 141(11):2656&#x2013;2667.e11. doi:&#xa0;10.1016/j.jid.2021.04.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2021.04.018</ArticleId><ArticleId IdType="pubmed">34004188</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu WD, Hu ZM, Shang MJ, Zhao DJ, Zhang CW, Hong DF, et al. . Cordycepin down-regulates multiple drug resistant (MDR)/HIF-1&#x3b1; through regulating AMPK/mTORC1 signaling in GBC-SD gallbladder cancer cells. Int J Mol Sci (2014) 15(7):12778&#x2013;90. doi:&#xa0;10.3390/ijms150712778</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms150712778</ArticleId><ArticleId IdType="pmc">PMC4139874</ArticleId><ArticleId IdType="pubmed">25046749</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo YM, Shin Y, Lee EJ, Lee S, Jeong SH, Kong HK, et al. . Inhibition of aerobic glycolysis represses Akt/mTOR/HIF-1&#x3b1; axis and restores tamoxifen sensitivity in antiestrogen-resistant breast cancer cells. PloS One (2015) 10(7):e0132285. doi:&#xa0;10.1371/journal.pone.0132285</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0132285</ArticleId><ArticleId IdType="pmc">PMC4497721</ArticleId><ArticleId IdType="pubmed">26158266</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Han L, Yu J, Li H, Li Q. miR-224 aggravates cancer-associated fibroblast-induced progression of non-small cell lung cancer by modulating a positive loop of the SIRT3/AMPK/mTOR/HIF-1&#x3b1; axis. Aging (2021) 13(7):10431&#x2013;49. doi:&#xa0;10.18632/aging.202803</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.202803</ArticleId><ArticleId IdType="pmc">PMC8064154</ArticleId><ArticleId IdType="pubmed">33819917</ArticleId></ArticleIdList></Reference><Reference><Citation>Maimaiti A, Aierken Y, Zhou L, He J, Abudureyimu A, Li SX. Inhibiting interleukin-6/Signal transducers and activators of transduction-3/Hypoxia-Inducible factor-1&#x3b1; signaling pathway suppressed the growth of infantile hemangioma. Eur J Pediatr Surg (2022) 12. doi:&#xa0;10.1055/s-0042-1749436</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1749436</ArticleId><ArticleId IdType="pubmed">35820438</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh H, Moore DJ, Markmann JF, Kim JI. Mechanisms of regulatory T cell counter-regulation by innate immunity. Transplant Rev (Orlando) (2013) 27(2):61&#x2013;4. doi:&#xa0;10.1016/j.trre.2013.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trre.2013.02.001</ArticleId><ArticleId IdType="pmc">PMC3637936</ArticleId><ArticleId IdType="pubmed">23474287</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SY, Lee AR, Choi JW, Lee CR, Cho KH, Lee JH, et al. . IL-17 induces autophagy dysfunction to promote inflammatory cell death and fibrosis in keloid fibroblasts via the STAT3 and HIF-1&#x3b1; dependent signaling pathways. Front Immunol (2022) 10:888719. doi:&#xa0;10.3389/fimmu.2022.888719</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.888719</ArticleId><ArticleId IdType="pmc">PMC9226909</ArticleId><ArticleId IdType="pubmed">35757697</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Wu D, Xu J, Liu L, Jiao W, Yu J, et al. . Suppression of NLRP3 inflammasome by dihydroarteannuin via the HIF-1&#x3b1; and JAK3/STAT3 signaling pathway contributes to attenuation of collagen-induced arthritis in mice. Front Pharmacol (2022) 27:884881. doi:&#xa0;10.3389/fphar.2022.884881</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.884881</ArticleId><ArticleId IdType="pmc">PMC9091180</ArticleId><ArticleId IdType="pubmed">35571141</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, You K, Bu R. Proximal tubular development is impaired with downregulation of MAPK/ERK signaling, HIF-1&#x3b1;, and catalase by hyperoxia exposure in neonatal rats. Oxid Med Cell Longev (2019) 28:2019. doi:&#xa0;10.1155/2019/9219847</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/9219847</ArticleId><ArticleId IdType="pmc">PMC6735195</ArticleId><ArticleId IdType="pubmed">31558952</ArticleId></ArticleIdList></Reference><Reference><Citation>Dom&#xe8;nech M, Hern&#xe1;ndez A, Plaja A, Mart&#xed;nez-Balibrea E, Bala&#xf1;&#xe0; C. Hypoxia: The cornerstone of glioblastoma. Int J Mol Sci (2021) 22(22):12608. doi:&#xa0;10.3390/ijms222212608</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222212608</ArticleId><ArticleId IdType="pmc">PMC8620858</ArticleId><ArticleId IdType="pubmed">34830491</ArticleId></ArticleIdList></Reference><Reference><Citation>Koedderitzsch K, Zezina E, Li L, Herrmann M, Biesemann N. TNF induces glycolytic shift in fibroblast like synoviocytes via GLUT1 and HIF1A. Sci Rep (2021) 11(1):19385. doi:&#xa0;10.1038/s41598-021-98651-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-98651-z</ArticleId><ArticleId IdType="pmc">PMC8481345</ArticleId><ArticleId IdType="pubmed">34588517</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Flach H, Onizawa M, Wei L, McManus MT, Weiss A. Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat Immunol (2014) 15(4):393&#x2013;401. doi:&#xa0;10.1038/ni.2846</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2846</ArticleId><ArticleId IdType="pmc">PMC3996831</ArticleId><ArticleId IdType="pubmed">24608041</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P, Wang J, Wen W, Pan T, Chen H, Fu Y, et al. . Cinnamaldehyde suppresses NLRP3 derived IL-1&#x3b2; via activating succinate/HIF-1 in rheumatoid arthritis rats. Int Immunopharmacol (2020) 84:106570. doi:&#xa0;10.1016/j.intimp.2020.106570</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.106570</ArticleId><ArticleId IdType="pubmed">32413739</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo HY, Yun M, Jeong J, Park ER, Shin HJ, Woo SR, et al. . SIRT1 deacetylates and stabilizes hypoxia-inducible factor-1&#x3b1; (HIF-1&#x3b1;) via direct interactions during hypoxia. Biochem Biophys Res Commun (2015) 462(4):294&#x2013;300. doi:&#xa0;10.1016/j.bbrc.2015.04.119</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.04.119</ArticleId><ArticleId IdType="pubmed">25979359</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Huang Y, Zhu L, Yang K, Liang K, Tan J, et al. . SIRT6 promotes angiogenesis and hemorrhage of carotid plaque via regulating HIF-1&#x3b1; and reactive oxygen species. Cell Death Dis (2021) 12(1):77. doi:&#xa0;10.1038/s41419-020-03372-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-03372-2</ArticleId><ArticleId IdType="pmc">PMC7804142</ArticleId><ArticleId IdType="pubmed">33436551</ArticleId></ArticleIdList></Reference><Reference><Citation>Fangradt M, Hahne M, Gaber T, Strehl C, Rauch R, Hoff P, et al. . Human monocytes and macrophages differ in their mechanisms of adaptation to hypoxia. Arthritis Res Ther (2012) 14(4):R181. doi:&#xa0;10.1186/ar4011</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar4011</ArticleId><ArticleId IdType="pmc">PMC3580576</ArticleId><ArticleId IdType="pubmed">22870988</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbarghati L, Murdoch C, Lewis CE. Effects of hypoxia on transcription factor expression in human monocytes and macrophages. Immunobiology (2008) 213(9-10):899&#x2013;908. doi:&#xa0;10.1016/j.imbio.2008.07.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2008.07.016</ArticleId><ArticleId IdType="pubmed">18926304</ArticleId></ArticleIdList></Reference><Reference><Citation>Staples KJ, Sotoodehnejadnematalahi F, Pearson H, Frankenberger M, Francescut L, Ziegler-Heitbrock L, et al. . Monocyte-derived macrophages matured under prolonged hypoxia transcriptionally up-regulate HIF-1&#x3b1; mRNA. Immunobiology (2011) 216(7):832&#x2013;9. doi:&#xa0;10.1016/j.imbio.2010.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2010.12.005</ArticleId><ArticleId IdType="pubmed">21281980</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y, Li X, Cheng Q, Hu Y, Chen X, Hua X, et al. . Single-cell transcriptomic identified HIF1A as a target for attenuating acute rejection after heart transplantation. Basic Res Cardiol (2021) 116(1):64. doi:&#xa0;10.1007/s00395-021-00904-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-021-00904-5</ArticleId><ArticleId IdType="pubmed">34870762</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Xie Y, Cui Z, Huang H, Yang C, Yuan B, et al. . Activation of hypoxia-inducible factor 1 (Hif-1) enhanced bactericidal effects of macrophages to mycobacterium tuberculosis. Tuberculosis (Edinb) (2021) 126:102044. doi:&#xa0;10.1016/j.tube.2020.102044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tube.2020.102044</ArticleId><ArticleId IdType="pubmed">33383382</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, et al. . Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1&#x3b1;/Glycolysis-Dependent axis. Cell Metab (2020) 32(3):498&#x2013;9. doi:&#xa0;10.1016/j.cmet.2020.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.07.015</ArticleId><ArticleId IdType="pmc">PMC7462530</ArticleId><ArticleId IdType="pubmed">32877692</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich D, Zapf D, Lohse B, Fecher RA, Deepe GS, Jr, Rupp J. The HIF-1&#x3b1;/LC3-II axis impacts fungal immunity in human macrophages. Infect Immun (2019) 87(7):e00125-19. doi:&#xa0;10.1128/IAI.00125-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00125-19</ArticleId><ArticleId IdType="pmc">PMC6589057</ArticleId><ArticleId IdType="pubmed">31036602</ArticleId></ArticleIdList></Reference><Reference><Citation>Christoph M, Pfluecke C, Mensch M, Augstein A, Jellinghaus S, Ende G, et al. . Myeloid PHD2 deficiency accelerates neointima formation via hif-1&#x3b1;. Mol Immunol (2022) 149:48&#x2013;58. doi:&#xa0;10.1016/j.molimm.2022.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2022.06.003</ArticleId><ArticleId IdType="pubmed">35724581</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammami A, Abidin BM, Charpentier T, Fabi&#xe9; A, Duguay AP, Heinonen KM, et al. . HIF-1&#x3b1; is a key regulator in potentiating suppressor activity and limiting the microbicidal capacity of MDSC-like cells during visceral leishmaniasis. PloS Pathog (2017) 13(9):e1006616. doi:&#xa0;10.1371/journal.ppat.1006616</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006616</ArticleId><ArticleId IdType="pmc">PMC5608422</ArticleId><ArticleId IdType="pubmed">28892492</ArticleId></ArticleIdList></Reference><Reference><Citation>Walmsley SR, Print C, Farahi N, Peyssonnaux C, RS J, Cramer T, et al. . Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med (2005) 201(1):105&#x2013;15. doi:&#xa0;10.1084/jem.20040624</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20040624</ArticleId><ArticleId IdType="pmc">PMC2212759</ArticleId><ArticleId IdType="pubmed">15630139</ArticleId></ArticleIdList></Reference><Reference><Citation>Willson JA, Arienti S, Sadiku P, Reyes L, Coelho P, Morrison T, et al. . Neutrophil HIF-1&#x3b1; stabilization is augmented by mitochondrial ROS produced via the glycerol 3-phosphate shuttle. Blood (2022) 139(2):281&#x2013;6. doi:&#xa0;10.1182/blood.2021011010</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021011010</ArticleId><ArticleId IdType="pmc">PMC8832465</ArticleId><ArticleId IdType="pubmed">34411229</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritzenwanger M, Jung C, Goebel B, Lauten A, Figulla HR. Impact of short-term systemic hypoxia on phagocytosis, cytokine production, and transcription factor activation in peripheral blood cells. Mediators Inflammation (2011) 2011:429501. doi:&#xa0;10.1155/2011/429501</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/429501</ArticleId><ArticleId IdType="pmc">PMC3134261</ArticleId><ArticleId IdType="pubmed">21765619</ArticleId></ArticleIdList></Reference><Reference><Citation>Elks PM, van Eeden FJ, Dixon G, Wang X, Reyes-Aldasoro CC, Ingham PW, et al. . Activation of hypoxia-inducible factor-1&#x3b1; (Hif-1&#x3b1;) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model. Blood (2011) 118(3):712&#x2013;22. doi:&#xa0;10.1182/blood-2010-12-324186</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-12-324186</ArticleId><ArticleId IdType="pubmed">21555741</ArticleId></ArticleIdList></Reference><Reference><Citation>Henneck T, Mergani A, Clever S, Seidler AE, Brogden G, Runft S, et al. . Formation of neutrophil extracellular traps by reduction of cellular cholesterol is independent of oxygen and HIF-1&#x3b1;. Int J Mol Sci (2022) 23(6):3195. doi:&#xa0;10.3390/ijms23063195</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23063195</ArticleId><ArticleId IdType="pmc">PMC8954871</ArticleId><ArticleId IdType="pubmed">35328617</ArticleId></ArticleIdList></Reference><Reference><Citation>McInturff AM, Cody MJ, Elliott EA, Glenn JW, Rowley JW, Rondina MT, et al. . Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 &#x3b1;. Blood (2012) 120(15):3118&#x2013;25. doi:&#xa0;10.1182/blood-2012-01-405993</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2012-01-405993</ArticleId><ArticleId IdType="pmc">PMC3471519</ArticleId><ArticleId IdType="pubmed">22919032</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris AJ, Mirchandani AS, Lynch RW, Murphy F, Delaney L, Small D, et al. . IL4R&#x3b1; signaling abrogates hypoxic neutrophil survival and limits acute lung injury responses in vivo. Am J Respir Crit Care Med. (2019) 200(2):235&#x2013;46. doi:&#xa0;10.1164/rccm.201808-1599OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201808-1599OC</ArticleId><ArticleId IdType="pmc">PMC6635795</ArticleId><ArticleId IdType="pubmed">30849228</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatib-Massalha E, Bhattacharya S, Massalha H, Biram A, Golan K, Kollet O, et al. . Lactate released by inflammatory bone marrow neutrophils induces their mobilization via endothelial GPR81 signaling. Nat Commun (2020) 11(1):3547. doi:&#xa0;10.1038/s41467-020-17402-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17402-2</ArticleId><ArticleId IdType="pmc">PMC7363928</ArticleId><ArticleId IdType="pubmed">32669546</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Wang H, Jiang B, Ni X, Jiang L, Li C, et al. . Loss of ATF3 exacerbates liver damage through the activation of mTOR/p70S6K/ HIF-1&#x3b1; signaling pathway in liver inflammatory injury. Cell Death Dis (2018) 9(9):910. doi:&#xa0;10.1038/s41419-018-0894-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0894-1</ArticleId><ArticleId IdType="pmc">PMC6125320</ArticleId><ArticleId IdType="pubmed">30185770</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinkernagel AS, Johnson RS, Nizet V. Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med (Berl) (2007) 85(12):1339&#x2013;46. doi:&#xa0;10.1007/s00109-007-0282-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-007-0282-2</ArticleId><ArticleId IdType="pubmed">18030436</ArticleId></ArticleIdList></Reference><Reference><Citation>Naldini A, Morena E, Pucci A, Miglietta D, Riboldi E, Sozzani S, et al. . Hypoxia affects dendritic cell survival: Role of the hypoxia-inducible factor-1&#x3b1; and lipopolysaccharide. J Cell Physiol (2012) 227(2):587&#x2013;95. doi:&#xa0;10.1002/jcp.22761</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.22761</ArticleId><ArticleId IdType="pubmed">21448921</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler T, Reizis B, Johnson RS, Weighardt H, F&#xf6;rster I. Influence of hypoxia-inducible factor 1&#x3b1; on dendritic cell differentiation and migration. Eur J Immunol (2012) 42(5):1226&#x2013;36. doi:&#xa0;10.1002/eji.201142053</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201142053</ArticleId><ArticleId IdType="pmc">PMC6592818</ArticleId><ArticleId IdType="pubmed">22539295</ArticleId></ArticleIdList></Reference><Reference><Citation>Jantsch J, Chakravortty D, Turza N, Prechtel AT, Buchholz B, Gerlach RG, et al. . Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J Immunol (2008) 180(7):4697&#x2013;705. doi:&#xa0;10.4049/jimmunol.180.7.4697</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.7.4697</ArticleId><ArticleId IdType="pubmed">18354193</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegert I, Sch&#xf6;del J, Nairz M, Schatz V, Dettmer K, Dick C, et al. . Ferritin-mediated iron sequestration stabilizes hypoxia-inducible factor-1&#x3b1; upon LPS activation in the presence of ample oxygen. Cell Rep (2015) 13(10):2048&#x2013;55. doi:&#xa0;10.1016/j.celrep.2015.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.11.005</ArticleId><ArticleId IdType="pubmed">26628374</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A. Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras hypoxia. J Biol Chem (2001) 276(12):9519&#x2013;25. doi:&#xa0;10.1074/jbc.M010144200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M010144200</ArticleId><ArticleId IdType="pubmed">11120745</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi I, Morena E, Aldinucci C, Carraro F, Sozzani S, Naldini A. Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1&#x3b1; and PI3K/Akt pathway. J Cell Physiol (2014) 229(12):2067&#x2013;76. doi:&#xa0;10.1002/jcp.24666</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.24666</ArticleId><ArticleId IdType="pubmed">24818793</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Zhang X, Chen K, Cheng Y, Liu S, Xia M, et al. . CCR7 chemokine receptor-inducible lnc-Dpf3 restrains dendritic cell migration by inhibiting HIF-1&#x3b1;-Mediated glycolysis. Immunity (2019) 50(3):600&#x2013;615.e15. doi:&#xa0;10.1016/j.immuni.2019.01.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.01.021</ArticleId><ArticleId IdType="pubmed">30824325</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari T, Olson J, Johnson RS, Nizet V. HIF-1 influences myeloid cell antigen presentation and response to subcutaneous OVA vaccination. J Mol Med (Berl). (2013) 91(10):1199&#x2013;205. doi:&#xa0;10.1007/s00109-013-1052-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-013-1052-y</ArticleId><ArticleId IdType="pmc">PMC3783576</ArticleId><ArticleId IdType="pubmed">23686259</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliesser M, Morton CO, Bonin M, Ebel F, H&#xfc;nniger K, Kurzai O, et al. . Hypoxia-inducible factor 1&#x3b1; modulates metabolic activity and cytokine release in anti-aspergillus fumigatus immune responses initiated by human dendritic cells. Int J Med Microbiol (2015) 305(8):865&#x2013;73. doi:&#xa0;10.1016/j.ijmm.2015.08.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmm.2015.08.036</ArticleId><ArticleId IdType="pubmed">26387061</ArticleId></ArticleIdList></Reference><Reference><Citation>Victorino F, Bigley TM, Park E, CH Y, Benoit J, LP Y, et al. . HIF1&#x3b1; is required for NK cell metabolic adaptation during virus infection. Elife (2021) 16:e68484. doi:&#xa0;10.7554/eLife.68484</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.68484</ArticleId><ArticleId IdType="pmc">PMC8382296</ArticleId><ArticleId IdType="pubmed">34396954</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei L, Lu J, Feng L, Long D, Shan J, Li S, et al. . HIF-1alpha accumulation upregulates MICA and MICB expression on human cardiomyocytes and enhances NK cell cytotoxicity during hypoxia-reoxygenation. Life Sci (2010) 87(3-4):111&#x2013;9. doi:&#xa0;10.1016/j.lfs.2010.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2010.05.012</ArticleId><ArticleId IdType="pubmed">20566410</ArticleId></ArticleIdList></Reference><Reference><Citation>Krzywinska E, Kantari-Mimoun C, Kerdiles Y, Sobecki M, Isagawa T, Gotthardt D, et al. . Loss of HIF-1&#x3b1; in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis. Nat Commun (2017) 8(1):1597. doi:&#xa0;10.1038/s41467-017-01599-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01599-w</ArticleId><ArticleId IdType="pmc">PMC5694012</ArticleId><ArticleId IdType="pubmed">29150606</ArticleId></ArticleIdList></Reference><Reference><Citation>Cluff E, Magdaleno CC, Fernandez E, House T, Swaminathan S, Varadaraj A, et al. . Hypoxia-inducible factor-1 alpha expression is induced by IL-2 via the PI3K/mTOR pathway in hypoxic NK cells and supports effector functions in NKL cells and ex vivo expanded NK cells. Cancer Immunol Immunother (2022) 71(8):1989&#x2013;2005. doi:&#xa0;10.1007/s00262-021-03126-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00262-021-03126-9</ArticleId><ArticleId IdType="pmc">PMC9294031</ArticleId><ArticleId IdType="pubmed">34999917</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulibaly A, Vel&#xe1;squez SY, Kassner N, Schulte J, Barbarossa MV, Lindner HA. STAT3 governs the HIF-1&#x3b1; response in IL-15 primed human NK cells. Sci Rep (2021) 11(1):7023. doi:&#xa0;10.1038/s41598-021-84916-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84916-0</ArticleId><ArticleId IdType="pmc">PMC8007797</ArticleId><ArticleId IdType="pubmed">33782423</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong HJ, Oh HA, Nam SY, Han NR, Kim YS, Kim JH, et al. . The critical role of mast cell-derived hypoxia-inducible factor-1&#x3b1; in human and mice melanoma growth. Int J Cancer (2013) 132(11):2492&#x2013;501. doi:&#xa0;10.1002/ijc.27937</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.27937</ArticleId><ArticleId IdType="pubmed">23161568</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumbayev VV, Yasinska I, Oniku AE, Streatfield CL, Gibbs BF. Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils. PloS One (2012) 7(3):e34259. doi:&#xa0;10.1371/journal.pone.0034259</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034259</ArticleId><ArticleId IdType="pmc">PMC3314605</ArticleId><ArticleId IdType="pubmed">22470546</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang X, Yin G, Ma Y, Xu K, Liu J, Li J. The critical role of mast cell-derived hypoxia-inducible factor-1&#x3b1; in regulating mast cell function. J Pharm Pharmacol (2016) 68(11):1409&#x2013;16. doi:&#xa0;10.1111/jphp</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jphp</ArticleId><ArticleId IdType="pubmed">27671226</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong HJ, Chung HS, Lee BR, Kim SJ, Yoo SJ, Hong SH, et al. . Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells. Biochem Biophys Res Commun (2003) 306(4):805&#x2013;11. doi:&#xa0;10.1016/s0006-291x(03)01073-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0006-291x(03)01073-8</ArticleId><ArticleId IdType="pubmed">12821113</ArticleId></ArticleIdList></Reference><Reference><Citation>Abebayehu D, Spence AJ, Qayum AA, Taruselli MT, McLeod JJ, Caslin HL, et al. . Lactic acid suppresses IL-33-Mediated mast cell inflammatory responses via hypoxia-inducible factor-1&#x3b1;-Dependent miR-155 suppression. J Immunol (2016) 197(7):2909&#x2013;17. doi:&#xa0;10.4049/jimmunol.1600651</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600651</ArticleId><ArticleId IdType="pmc">PMC5026940</ArticleId><ArticleId IdType="pubmed">27559047</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Nardo A, Vitiello A, Gallo RL. Cutting edge: Mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol (2003) 170(5):2274&#x2013;8. doi:&#xa0;10.4049/jimmunol.170.5.2274</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.5.2274</ArticleId><ArticleId IdType="pubmed">12594247</ArticleId></ArticleIdList></Reference><Reference><Citation>Branitzki-Heinemann K, Okumura CY, V&#xf6;llger L, Kawakami Y, Kawakami T, Naim HY, et al. . A novel role for the transcription factor HIF-1&#x3b1; in the formation of mast cell extracellular traps. Biochem J (2012) 446(1):159&#x2013;63. doi:&#xa0;10.1042/BJ20120658</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20120658</ArticleId><ArticleId IdType="pmc">PMC3606900</ArticleId><ArticleId IdType="pubmed">22738198</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Feng C, Qin J, Li D, Liu M, Han S, et al. . Regulation of humoral immune response by HIF-1&#x3b1;-dependent metabolic reprogramming of the germinal center reaction. Cell Immunol (2021) 367:104409. doi:&#xa0;10.1016/j.cellimm.2021.104409</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2021.104409</ArticleId><ArticleId IdType="pubmed">34246872</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Huo J, Huang Y, Aw M, Chen S, Mak S, et al. . Von hippel-lindau protein maintains metabolic balance to regulate the survival of naive b lymphocytes. iScience (2019) 26:17. doi:&#xa0;10.1016/j.isci.2019.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2019.07.002</ArticleId><ArticleId IdType="pmc">PMC6660606</ArticleId><ArticleId IdType="pubmed">31351078</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima H, Kobayashi A, Sakurai D, Kanno Y, Hase H, Takahashi R, et al. . Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha-regulated glycolytic pathway during murine b cell development in bone marrow. J Immunol (2010) 184(1):154&#x2013;63. doi:&#xa0;10.4049/jimmunol.0800167</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0800167</ArticleId><ArticleId IdType="pmc">PMC2848717</ArticleId><ArticleId IdType="pubmed">19949104</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrows N, Bashford-Rogers RJM, Bhute VJ, Pe&#xf1;alver A, Ferdinand JR, Stewart BJ, et al. . Dynamic regulation of hypoxia-inducible factor-1&#x3b1; activity is essential for normal b cell development. Nat Immunol (2020) 21(11):1408&#x2013;20. doi:&#xa0;10.1038/s41590-020-0772-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0772-8</ArticleId><ArticleId IdType="pmc">PMC7613233</ArticleId><ArticleId IdType="pubmed">32868930</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X, Gr&#xf6;tsch B, Luo Y, Knaup KX, Wiesener MS, Chen XX, et al. . Hypoxia-inducible factor-1&#x3b1; is a critical transcription factor for IL-10-producing b cells in autoimmune disease. Nat Commun (2018) 9(1):251. doi:&#xa0;10.1038/s41467-017-02683-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02683-x</ArticleId><ArticleId IdType="pmc">PMC5772476</ArticleId><ArticleId IdType="pubmed">29343683</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho SH, Raybuck AL, Stengel K, Wei M, Beck TC, Volanakis E, et al. . Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system. Nature (2016) 537(7619):234&#x2013;8. doi:&#xa0;10.1038/nature19334</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19334</ArticleId><ArticleId IdType="pmc">PMC5161594</ArticleId><ArticleId IdType="pubmed">27501247</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F, Liu H, Xu L, Li Y, Liu X, Shi L, et al. . Hypoxia-inducible factor-1&#x3b1; perpetuates synovial fibroblast interactions with T cells and b cells in rheumatoid arthritis. Eur J Immunol (2016) 46(3):742&#x2013;51. doi:&#xa0;10.1002/eji.201545784</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545784</ArticleId><ArticleId IdType="pubmed">26604208</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang JW, Park S, Moon EY. Spleen tyrosine kinase regulates crosstalk of hypoxia-inducible factor-1&#x3b1; and nuclear factor (erythroid-derived2)-like 2 for b cell survival. Int Immunopharmacol (2021) 95:107509. doi:&#xa0;10.1016/j.intimp.2021.107509</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107509</ArticleId><ArticleId IdType="pubmed">33761438</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang JW, Thuy PX, Lee JW, Moon EY. CXCR4 promotes b cell viability by the cooperation of nuclear factor (erythroid-derived 2)-like 2 and hypoxia-inducible factor-1&#x3b1; under hypoxic conditions. Cell Death Dis (2021) 12(4):330. doi:&#xa0;10.1038/s41419-021-03615-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03615-w</ArticleId><ArticleId IdType="pmc">PMC7998033</ArticleId><ArticleId IdType="pubmed">33771976</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhari SM, Sluimer JC, Koch M, Theelen TL, Manthey HD, Busch M, et al. . Deficiency of HIF1&#x3b1; in antigen-presenting cells aggravates atherosclerosis and type 1 T-helper cell responses in mice. Arterioscler Thromb Vasc Biol (2015) 35(11):2316&#x2013;25. doi:&#xa0;10.1161/ATVBAHA.115.306171</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.115.306171</ArticleId><ArticleId IdType="pmc">PMC4618712</ArticleId><ArticleId IdType="pubmed">26404487</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks E, Naudin C, Nolan G, Goggins BJ, Burns G, Mateer SW, et al. . Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation. Mucosal Immunol (2017) 10(5):1224&#x2013;36. doi:&#xa0;10.1038/mi.2016.135</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2016.135</ArticleId><ArticleId IdType="pubmed">28120851</ArticleId></ArticleIdList></Reference><Reference><Citation>Westendorf AM, Skibbe K, Adamczyk A, Buer J, Geffers R, Hansen W, et al. . Hypoxia enhances immunosuppression by inhibiting CD4+ effector T cell function and promoting treg activity. Cell Physiol Biochem (2017) 41(4):1271&#x2013;84. doi:&#xa0;10.1159/000464429</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000464429</ArticleId><ArticleId IdType="pubmed">28278498</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammami A, Abidin BM, Heinonen KM, St&#xe4;ger S. HIF-1&#x3b1; hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis. Sci Rep (2018) 8(1):3500. doi:&#xa0;10.1038/s41598-018-21891-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-21891-z</ArticleId><ArticleId IdType="pmc">PMC5823892</ArticleId><ArticleId IdType="pubmed">29472618</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan C, Bi W, Lin P, Zhang Y, Tian J, Fang S, et al. . MicroRNA 182 promotes T helper 1 cell by repressing hypoxia induced factor 1 alpha in experimental autoimmune encephalomyelitis. Eur J Immunol (2019) 49(12):2184&#x2013;94. doi:&#xa0;10.1002/eji.201948111</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201948111</ArticleId><ArticleId IdType="pubmed">31411745</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KS, Kim SR, Park SJ, Park HS, Min KH, Jin SM, et al. . Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice. J Allergy Clin Immunol (2006) 118(1):120&#x2013;7. doi:&#xa0;10.1016/j.jaci.2006.03.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2006.03.021</ArticleId><ArticleId IdType="pubmed">16815147</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu Y, Wang J, Li Z, Yao K, Wang L, Song J. HIF1&#x3b1; deficiency in dendritic cells attenuates symptoms and inflammatory indicators of allergic rhinitis in a SIRT1-dependent manner. Int Arch Allergy Immunol (2020) 181(8):585&#x2013;93. doi:&#xa0;10.1159/000506862</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000506862</ArticleId><ArticleId IdType="pubmed">32541149</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang TY, Park CS, Kim KS, Heo MJ, Kim YH. Benzaldehyde suppresses murine allergic asthma and rhinitis. Int Immunopharmacol (2014) 22(2):444&#x2013;50. doi:&#xa0;10.1016/j.intimp.2014.07.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2014.07.029</ArticleId><ArticleId IdType="pubmed">25107441</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo JH, Kim JH, Lim DJ, Kim EH. The role of hypoxia-inducible factor 1&#x3b1; in allergic rhinitis. Am J Rhinol Allergy (2014) 28(2):e100&#x2013;6. doi:&#xa0;10.2500/ajra.2014.28.4025</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/ajra.2014.28.4025</ArticleId><ArticleId IdType="pubmed">24717944</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza Alves CC, Collison A, Hatchwell L, Plank M, Morten M, Foster PS, et al. . Inhibiting AKT phosphorylation employing non-cytotoxic anthraquinones ameliorates TH2 mediated allergic airways disease and rhinovirus exacerbation. PloS One (2013) 8(11):e79565. doi:&#xa0;10.1371/journal.pone.0079565</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079565</ArticleId><ArticleId IdType="pmc">PMC3818233</ArticleId><ArticleId IdType="pubmed">24223970</ArticleId></ArticleIdList></Reference><Reference><Citation>PXiong Y, Lingrel JB, W&#xfc;thrich M, Klein BS, Vasudevan NT, Jain MK, et al. . Transcription factor KLF2 in dendritic cells downregulates Th2 programming via the HIF-1&#x3b1;/Jagged2/Notch axis. mBio (2016) 7(3):e00436&#x2013;16. doi:&#xa0;10.1128/mBio.00436-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00436-16</ArticleId><ArticleId IdType="pmc">PMC4916374</ArticleId><ArticleId IdType="pubmed">27302755</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, Wang L, Zhou J, Zhang X. HIF-1&#x3b1; inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. J Transl Med (2017) 15(1):28. doi:&#xa0;10.1186/s12967-017-1132-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1132-9</ArticleId><ArticleId IdType="pmc">PMC5301444</ArticleId><ArticleId IdType="pubmed">28183349</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Yang J, Saren G, Zhao H, Cao K, Fu S, et al. . HDAC6-specific inhibitor suppresses Th17 cell function via the HIF-1&#x3b1; pathway in acute lung allograft rejection in mice. Theranostics (2020) 10(15):6790&#x2013;805. doi:&#xa0;10.7150/thno.44961</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.44961</ArticleId><ArticleId IdType="pmc">PMC7295069</ArticleId><ArticleId IdType="pubmed">32550904</ArticleId></ArticleIdList></Reference><Reference><Citation>Groneberg M, Hoenow S, Marggraff C, Fehling H, Metwally NG, Hansen C, et al. . HIF-1&#x3b1; modulates sex-specific Th17/Treg responses during hepatic amoebiasis. J Hepatol (2022) 76(1):160&#x2013;73. doi:&#xa0;10.1016/j.jhep.2021.09.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2021.09.020</ArticleId><ArticleId IdType="pubmed">34599999</ArticleId></ArticleIdList></Reference><Reference><Citation>kejiri A, Nagai S, Goda N, Kurebayashi Y, Osada-Oka M, Takubo K, et al. . Dynamic regulation of Th17 differentiation by oxygen concentrations. Int Immunol (2012) 24(3):137&#x2013;46. doi:&#xa0;10.1093/intimm/dxr111</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxr111</ArticleId><ArticleId IdType="pubmed">22207131</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Li W, Zhu W, He W, Zhao H, Xiang Y, et al. . Chronic intermittent hypoxia promotes the development of experimental non-alcoholic steatohepatitis by modulating Treg/Th17 differentiation. Acta Biochim Biophys Sin (Shanghai) (2018) 50(12):1200&#x2013;10. doi:&#xa0;10.1093/abbs/gmy131</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmy131</ArticleId><ArticleId IdType="pubmed">30379980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Tian T, Gao J, Liu X, Hou H, Cao R, et al. . Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice. J Neuroimmunol (2016) 15:58&#x2013;67. doi:&#xa0;10.1016/j.jneuroim.2016.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2016.01.014</ArticleId><ArticleId IdType="pubmed">26943960</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang EJ, Lee J, Lee SY, Kim EK, Moon YM, Jung YO, et al. . EGCG attenuates autoimmune arthritis by inhibition of STAT3 and HIF-1&#x3b1; with Th17/Treg control. PloS One (2014) 9(2):e86062. doi:&#xa0;10.1371/journal.pone.0086062</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0086062</ArticleId><ArticleId IdType="pmc">PMC3928092</ArticleId><ArticleId IdType="pubmed">24558360</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Wang L, Jiang J, Lin S, Luo A, Zhao P, et al. . Critical role of AdipoR1 in regulating Th17 cell differentiation through modulation of HIF-1&#x3b1;-Dependent glycolysis. Front Immunol (2020) 18:2040. doi:&#xa0;10.3389/fimmu.2020.02040</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.02040</ArticleId><ArticleId IdType="pmc">PMC7461876</ArticleId><ArticleId IdType="pubmed">32973810</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerriets VA, Danzaki K, Kishton RJ, Eisner W, Nichols AG, Saucillo DC, et al. . Leptin directly promotes T-cell glycolytic metabolism to drive effector T-cell differentiation in a mouse model of autoimmunity. Eur J Immunol (2016) 46(8):1970&#x2013;83. doi:&#xa0;10.1002/eji.201545861</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545861</ArticleId><ArticleId IdType="pmc">PMC5154618</ArticleId><ArticleId IdType="pubmed">27222115</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarvis LB, Rainbow DB, Coppard V, Howlett SK, Georgieva Z, Davies JL, et al. . Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73. Commun Biol (2021) 4(1):1186. doi:&#xa0;10.1038/s42003-021-02721-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02721-x</ArticleId><ArticleId IdType="pmc">PMC8516976</ArticleId><ArticleId IdType="pubmed">34650224</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei P, Shen W, Zhang Y, Zhang Y, Qi Z, Zhou H, et al. . Radioactive nano-oxygen generator enhance anti-tumor radio-immunotherapy by regulating tumor microenvironment and reducing proliferation. Biomaterials (2022) 280:121326. doi:&#xa0;10.1016/j.biomaterials.2021.121326</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2021.121326</ArticleId><ArticleId IdType="pubmed">34953386</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollinger T, Gies S, Naujoks J, Feldhoff L, Bollinger A, Solbach W, et al. . HIF-1&#x3b1;- and hypoxia-dependent immune responses in human CD4+CD25high T cells and T helper 17 cells. J Leukoc Biol (2014) 96(2):305&#x2013;12. doi:&#xa0;10.1189/jlb.3A0813-426RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.3A0813-426RR</ArticleId><ArticleId IdType="pubmed">24664971</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldhoff LM, Rueda CM, Moreno-Fernandez ME, Sauer J, Jackson CM, Chougnet CA, et al. . IL-1&#x3b2; induced HIF-1&#x3b1; inhibits the differentiation of human FOXP3+ T cells. Sci Rep (2017) 7(1):465. doi:&#xa0;10.1038/s41598-017-00508-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00508-x</ArticleId><ArticleId IdType="pmc">PMC5428734</ArticleId><ArticleId IdType="pubmed">28352109</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazon A, Tyrakis PA, Macias D, Veli&#xe7;a P, Rundqvist H, Fitzpatrick S, et al. . An HIF-1&#x3b1;/VEGF-A axis in cytotoxic T cells regulates tumor progression. Cancer Cell (2017) 32(5):669&#x2013;683.e5. doi:&#xa0;10.1016/j.ccell.2017.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2017.10.003</ArticleId><ArticleId IdType="pmc">PMC5691891</ArticleId><ArticleId IdType="pubmed">29136509</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta SS, Sharp R, Hofferek C, Kuai L, Dorn GW, 2nd, Wang J, et al. . NIX-mediated mitophagy promotes effector memory formation in antigen-specific CD8+ T cells. Cell Rep (2019) 29(7):1862&#x2013;77. doi:&#xa0;10.1016/j.celrep.2019.10.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.10.032</ArticleId><ArticleId IdType="pmc">PMC6886713</ArticleId><ArticleId IdType="pubmed">31722203</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortezaee K, Majidpoor J. The impact of hypoxia on immune state in cancer. Life Sci (2021) 286:120057. doi:&#xa0;10.1016/j.lfs.2021.120057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.120057</ArticleId><ArticleId IdType="pubmed">34662552</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha J, Sarkar D, Pramanik A, Mahanti K, Adhikary A, Bhattacharyya S. PGE2-HIF1&#x3b1; reciprocal induction regulates migration, phenotypic alteration and immunosuppressive capacity of macrophages in tumor microenvironment. Life Sci (2020) 253:117731. doi:&#xa0;10.1016/j.lfs.2020.117731</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117731</ArticleId><ArticleId IdType="pubmed">32353431</ArticleId></ArticleIdList></Reference><Reference><Citation>Liikanen I, Lauhan C, Quon S, Omilusik K, AT P, LB Bartrol&#xed;, et al. . Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells. J Clin Invest. (2021) 131(7):e143729. doi:&#xa0;10.1172/JCI143729</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI143729</ArticleId><ArticleId IdType="pmc">PMC8011896</ArticleId><ArticleId IdType="pubmed">33792560</ArticleId></ArticleIdList></Reference><Reference><Citation>Doedens AL, Phan AT, Stradner MH, Fujimoto JK, Nguyen JV, Yang E, et al. . Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol (2013) 14(11):1173&#x2013;82. doi:&#xa0;10.1038/ni.2714</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2714</ArticleId><ArticleId IdType="pmc">PMC3977965</ArticleId><ArticleId IdType="pubmed">24076634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y, Zuo Y, He M, Duo L, Chen X, Tang W. Clinical predictive model to estimate probability of remission in patients with lupus nephritis. Int Immunopharmacol (2022) 110:108966. doi:&#xa0;10.1016/j.intimp.2022.108966</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.108966</ArticleId><ArticleId IdType="pubmed">35764016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C, Wei J, Zhan F, Wang R, Fu K, Wan X, et al. . Urinary hypoxia-inducible factor-1alpha levels are associated with histologic chronicity changes and renal function in patients with lupus nephritis. Yonsei Med J (2012) 53(3):587&#x2013;92. doi:&#xa0;10.3349/ymj.2012.53.3.587</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2012.53.3.587</ArticleId><ArticleId IdType="pmc">PMC3343432</ArticleId><ArticleId IdType="pubmed">22477004</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng CC, QL Ye, Zhu Y, Leng RX, Chen GM, Yang J, et al. . Lack of association between the polymorphisms of hypoxia-inducible factor 1A (HIF1A) gene and SLE susceptibility in a Chinese population. Immunogenetics (2014) 66(1):9&#x2013;13. doi:&#xa0;10.1007/s00251-013-0743-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00251-013-0743-4</ArticleId><ArticleId IdType="pubmed">24232601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kono M, Yoshida N, Maeda K, Su&#xe1;rez-Fueyo A, Kyttaris VC, Tsokos GC. Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus-like disease in MRL/lpr mice and experimental autoimmune encephalomyelitis. Arthritis Rheumatol (2019) 71(11):1869&#x2013;78. doi:&#xa0;10.1002/art.41019</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41019</ArticleId><ArticleId IdType="pmc">PMC6817384</ArticleId><ArticleId IdType="pubmed">31233276</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn JK, Koh EM, Cha HS, Lee YS, Kim J, Bae EK, et al. . Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes. Rheumatol (Oxford) (2008) 47(6):834&#x2013;9. doi:&#xa0;10.1093/rheumatology/ken086</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken086</ArticleId><ArticleId IdType="pubmed">18400834</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer E, Gouw AS, Posthumus MD, van Leeuwen MA, Boerboom AL, Bijzet J, et al. . Hypoxia inducible factor-1-alpha (HIF-1alpha) is related to both angiogenesis and inflammation in rheumatoid arthritis. Clin Exp Rheumatol (2009) 27(6):945&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">20149310</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Cheng W, Li J, Wang Y, Chen J, Shen X, et al. . Notch-1 and notch-3 mediate hypoxia-induced activation of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheumatol (2021) 73(10):1810&#x2013;9. doi:&#xa0;10.1002/art.41748</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41748</ArticleId><ArticleId IdType="pubmed">33844448</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai L, Chen SZ, Liang S, SS Li, Wang W. [The influence of tripterygium hypoglaucum hutch on the HIF-1&#x3b1; expression in the CIA rat models]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2011) 27(10):1061&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">21968302</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Z, Ouyang L, Gong Y, Wang Z, Yu B. Effect of eriodictyol on collagen-induced arthritis in rats by Akt/HIF-1&#x3b1; pathway. Drug Des Devel Ther (2020) 29:1633&#x2013;9. doi:&#xa0;10.2147/DDDT.S239662</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S239662</ArticleId><ArticleId IdType="pmc">PMC7196781</ArticleId><ArticleId IdType="pubmed">32425508</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XJ, Liu J, Wan L, Sun Y, Wang F, YJ Qi, et al. . [Relations of synovial angiogenesis and PTEN/PI3K/AKT signaling pathway in rats with adjuvant arthritis]. Zhongguo Gu Shang (2015) 28(1):71&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">25823138</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng B, Liu FY, Liu MM, Yu LC, Zhang WT, Zhou MY, et al. . AMSP-30 m as a novel HIF-1&#x3b1; inhibitor attenuates the development and severity of adjuvant-induced arthritis in rats: Impacts on synovial apoptosis, synovial angiogenesis and sonic hedgehog signaling pathway. Int Immunopharmacol (2022) 103:108467. doi:&#xa0;10.1016/j.intimp.2021.108467</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108467</ArticleId><ArticleId IdType="pubmed">34933161</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang TT, CF Ji, Cheng XP, Gu SF, Wang R, Li Y, et al. . &#x3b1;-mangostin alleviated HIF-1&#x3b1;-Mediated angiogenesis in rats with adjuvant-induced arthritis by suppressing aerobic glycolysis. Front Pharmacol (2021) 20:785586. doi:&#xa0;10.3389/fphar.2021.785586</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.785586</ArticleId><ArticleId IdType="pmc">PMC8721667</ArticleId><ArticleId IdType="pubmed">34987400</ArticleId></ArticleIdList></Reference><Reference><Citation>Westra J, Brouwer E, Bouwman E, Doornbos-van der Meer B, Posthumus MD, van Leeuwen MA, et al. . Role for CaMKII inhibition in rheumatoid arthritis: Effects on HIF-1-induced VEGF production by rheumatoid synovial fibroblasts. Ann N Y Acad Sci (2009) 1173:706&#x2013;11. doi:&#xa0;10.1111/j.1749-6632.2009.04736.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2009.04736.x</ArticleId><ArticleId IdType="pubmed">19758219</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng ZT, Yang T, Hou XQ, Wu HY, Feng JT, Ou BJ, et al. . Sinomenine mitigates collagen-induced arthritis mice by inhibiting angiogenesis. BioMed Pharmacother (2019) 113:108759. doi:&#xa0;10.1016/j.biopha.2019.108759</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.108759</ArticleId><ArticleId IdType="pubmed">30856539</ArticleId></ArticleIdList></Reference><Reference><Citation>Li GQ, Zhang Y, Liu D, Qian YY, Zhang H, Guo SY, et al. . PI3 kinase/Akt/HIF-1&#x3b1; pathway is associated with hypoxia-induced epithelial-mesenchymal transition in fibroblast-like synoviocytes of rheumatoid arthritis. Mol Cell Biochem (2013) 372(1-2):221&#x2013;31. doi:&#xa0;10.1007/s11010-012-1463-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-012-1463-z</ArticleId><ArticleId IdType="pubmed">23001847</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Wei X, Jiao Y, Bai Y, Sam WN, Yan Q, et al. . STAT3/HIF-1&#x3b1;/fascin-1 axis promotes RA FLSs migration and invasion ability under hypoxia. Mol Immunol (2022) 142:83&#x2013;94. doi:&#xa0;10.1016/j.molimm.2021.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2021.12.004</ArticleId><ArticleId IdType="pubmed">34971867</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Zhang Y, Qian Y, Zhang H, Guo S, Sunagawa M, et al. . Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-&#x3ba;B/HIF-1&#x3b1; pathway. Mol Immunol (2013) 53(3):227&#x2013;36. doi:&#xa0;10.1016/j.molimm.2012.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2012.08.018</ArticleId><ArticleId IdType="pubmed">22960198</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulley PA, Bishop T, Vernet A. Hypoxia-inducible factor 1-alpha does not regulate osteoclastogenesis but enhances bone resorption activity via prolyl-4-hydroxylase 2. J Pathol (2017) 242(3):322&#x2013;33. doi: 10.1002/path.4906</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4906</ArticleId><ArticleId IdType="pmc">PMC5518186</ArticleId><ArticleId IdType="pubmed">28418093</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles HJ. Distinct roles for the hypoxia-inducible transcription factors HIF-1&#x3b1; and HIF-2&#x3b1; in human osteoclast formation and function. Sci Rep (2020) 10(1):21072. doi:&#xa0;10.1038/s41598-020-78003-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-78003-z</ArticleId><ArticleId IdType="pmc">PMC7713367</ArticleId><ArticleId IdType="pubmed">33273561</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F, Mu R, Zhu J, Shi L, Li Y, Liu X, et al. . Hypoxia and hypoxia-inducible factor-1&#x3b1; provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Ann Rheum Dis (2014) 73(5):928&#x2013;36. doi:&#xa0;10.1136/annrheumdis-2012-202444</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2012-202444</ArticleId><ArticleId IdType="pubmed">23644550</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu R, Li C, Sun L, Jian L, Ma Z, Zhao J, et al. . Hypoxia induces production of citrullinated proteins in human fibroblast-like synoviocytes through regulating HIF1&#x3b1;. Scand J Immunol (2018) 87(4):e12654. doi:&#xa0;10.1111/sji.12654</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12654</ArticleId><ArticleId IdType="pubmed">29484680</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Liu Y, Wang C, WR X, Zheng JY, Yang J, et al. . Succinate induces synovial angiogenesis in rheumatoid arthritis through metabolic remodeling and HIF-1&#x3b1;/VEGF axis. Free Radic Biol Med (2018) 126:1&#x2013;14. doi:&#xa0;10.1016/j.freeradbiomed.2018.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.07.009</ArticleId><ArticleId IdType="pubmed">30030103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding LL, Li X, Lei YM, Xia LP, Lu J, Shen H. Effect of interleukin-34 on secretion of angiogenesis cytokines by peripheral blood mononuclear cells of rheumatoid arthritis. Immunol Invest (2020) 49(1-2):81&#x2013;7. doi:&#xa0;10.1080/08820139.2019.1649281</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08820139.2019.1649281</ArticleId><ArticleId IdType="pubmed">31401905</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei B, Chen K, Zhou S, Min D, Xiao W. IL-38 restrains inflammatory response of collagen-induced arthritis in rats via SIRT1/HIF-1&#x3b1; signaling pathway. Biosci Rep (2020) 40(5). doi:&#xa0;10.1042/BSR20182431</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20182431</ArticleId><ArticleId IdType="pmc">PMC7256678</ArticleId><ArticleId IdType="pubmed">32347300</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles HJ, Cleton-Jansen AM, Korsching E, Athanasou NA. Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: Role of angiopoietin-like 4. FASEB J (2010) 24(12):4648&#x2013;59. doi:&#xa0;10.1096/fj.10-162230</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.10-162230</ArticleId><ArticleId IdType="pmc">PMC2992372</ArticleId><ArticleId IdType="pubmed">20667978</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Masi&#xe1; D, Cos&#xed;n-Roger J, Calatayud S, Hern&#xe1;ndez C, Al&#xf3;s R, Hinojosa J, et al. . M1 macrophages activate notch signalling in epithelial cells: Relevance in crohn's disease. J Crohns Colitis (2016) 10(5):582&#x2013;92. doi:&#xa0;10.1093/ecco-jcc/jjw009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjw009</ArticleId><ArticleId IdType="pmc">PMC4957456</ArticleId><ArticleId IdType="pubmed">26802079</ArticleId></ArticleIdList></Reference><Reference><Citation>Hume GE, Doecke JD, Huang N, Fowler EV, Brown IS, Simms LA, et al. . Altered expression of angiotensinogen and mediators of angiogenesis in ileal crohn's disease. J Gastrointestin Liver Dis (2016) 25(1):39&#x2013;48. doi:&#xa0;10.15403/jgld.2014.1121.251.chr</Citation><ArticleIdList><ArticleId IdType="doi">10.15403/jgld.2014.1121.251.chr</ArticleId><ArticleId IdType="pubmed">27014752</ArticleId></ArticleIdList></Reference><Reference><Citation>Senhaji N, Nadifi S, Zaid Y, Serrano A, Rodriguez DAL, Serbati N, et al. . Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease. World J Gastroenterol (2017) 23(47):8300&#x2013;7. doi:&#xa0;10.3748/wjg.v23.i47.8300</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v23.i47.8300</ArticleId><ArticleId IdType="pmc">PMC5743501</ArticleId><ArticleId IdType="pubmed">29307990</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu MM, Wang QM, Huang BY, Mai CT, Wang CL, Wang TT, et al. . Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization. Pharmacol Res (2021) 172:105796. doi:&#xa0;10.1016/j.phrs.2021.105796</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105796</ArticleId><ArticleId IdType="pubmed">34343656</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang H, Lv Q, Zhong C, Cui Y, He L, Zhang C, et al. . Tiliroside ameliorates ulcerative colitis by restoring the M1/M2 macrophage balance via the HIF-1&#x3b1;/glycolysis pathway. Front Immunol (2021) 31:649463. doi:&#xa0;10.3389/fimmu.2021.649463</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.649463</ArticleId><ArticleId IdType="pmc">PMC8044352</ArticleId><ArticleId IdType="pubmed">33868286</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H, Lin J, Xu C, Sun M, Zuo K, Zhang X, et al. . Cyclosporine modulates neutrophil functions via the SIRT6-HIF-1&#x3b1;-glycolysis axis to alleviate severe ulcerative colitis. Clin Transl Med (2021) 11(2):e334. doi:&#xa0;10.1002/ctm2.334</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.334</ArticleId><ArticleId IdType="pmc">PMC7882115</ArticleId><ArticleId IdType="pubmed">33634990</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n-Pe&#xf1;a S, O'Neill LA. Metabolic reprograming in macrophage polarization. Front Immunol (2014) 2:420. doi:&#xa0;10.3389/fimmu.2014.00420</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00420</ArticleId><ArticleId IdType="pmc">PMC4151090</ArticleId><ArticleId IdType="pubmed">25228902</ArticleId></ArticleIdList></Reference><Reference><Citation>Mimouna S, Gon&#xe7;alv&#xe8;s D, Barnich N, Darfeuille-Michaud A, Hofman P, Vouret-Craviari V. Crohn disease-associated escherichia coli promote gastrointestinal inflammatory disorders by activation of HIF-dependent responses. Gut Microbes (2011) 2(6):335&#x2013;46. doi:&#xa0;10.4161/gmic.18771</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/gmic.18771</ArticleId><ArticleId IdType="pubmed">22157238</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, He C, Wu W, Zhou G, Liu F, Cong Y, et al. . Hypoxia inducible factor-1&#x3b1;-induced interleukin-33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease. Clin Exp Immunol (2017) 187(3):428&#x2013;40. doi:&#xa0;10.1111/cei.12896</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12896</ArticleId><ArticleId IdType="pmc">PMC5290230</ArticleId><ArticleId IdType="pubmed">27921309</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown E, Rowan C, Strowitzki MJ, Fagundes RR, Faber KN, G&#xfc;ntsch A, et al. . Mucosal inflammation downregulates PHD1 expression promoting a barrier-protective HIF-1&#x3b1; response in ulcerative colitis patients. FASEB J (2020) 34(3):3732&#x2013;42. doi:&#xa0;10.1096/fj.201902103R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201902103R</ArticleId><ArticleId IdType="pubmed">31944416</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Wei C, Yao J, Cai X, Wang L. Interleukin-10 gene-carrying bifidobacteria ameliorate murine ulcerative colitis by regulating regulatory T cell/T helper 17 cell pathway. Exp Biol Med (Maywood) (2015) 240(12):1622&#x2013;9. doi:&#xa0;10.1177/1535370215584901</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370215584901</ArticleId><ArticleId IdType="pmc">PMC4935350</ArticleId><ArticleId IdType="pubmed">25956685</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindryckx P, De Vos M, Jacques P, Ferdinande L, Peeters H, Olievier K, et al. . Hydroxylase inhibition abrogates TNF-alpha-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD. J Immunol (2010) 185(10):6306&#x2013;16. doi:&#xa0;10.4049/jimmunol.1002541</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1002541</ArticleId><ArticleId IdType="pubmed">20943999</ArticleId></ArticleIdList></Reference><Reference><Citation>Fl&#xfc;ck K, Breves G, Fandrey J, Winning S. Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis. Mucosal Immunol (2016) 9(2):379&#x2013;90. doi:&#xa0;10.1038/mi.2015.67</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2015.67</ArticleId><ArticleId IdType="pubmed">26220168</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashiyama M, Hokari R, Hozumi H, Kurihara C, Ueda T, Watanabe C, et al. . HIF-1 in T cells ameliorated dextran sodium sulfate-induced murine colitis. J Leukoc Biol (2012) 91(6):901&#x2013;9. doi:&#xa0;10.1189/jlb.1011518</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1011518</ArticleId><ArticleId IdType="pubmed">22457366</ArticleId></ArticleIdList></Reference><Reference><Citation>Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest (2004) 114(8):1098&#x2013;106. doi:&#xa0;10.1172/JCI21086</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI21086</ArticleId><ArticleId IdType="pmc">PMC522241</ArticleId><ArticleId IdType="pubmed">15489957</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin N, Shay JES, Xie H, Lee DSM, Skuli N, Tang Q, et al. . Myeloid cell hypoxia-inducible factors promote resolution of inflammation in experimental colitis. Front Immunol (2018) 5:2565. doi:&#xa0;10.3389/fimmu.2018.02565</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02565</ArticleId><ArticleId IdType="pmc">PMC6230677</ArticleId><ArticleId IdType="pubmed">30455703</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou M, Pyrpasopoulou A, Simos G, Paraskeva E, Nikolaidou C, Venizelos I, et al. . Upregulation of VEGF expression is associated with accumulation of HIF-1&#x3b1; in the skin of na&#xef;ve scleroderma patients. Mod Rheumatol (2013) 23(6):1245&#x2013;8. doi:&#xa0;10.1007/s10165-012-0787-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10165-012-0787-6</ArticleId><ArticleId IdType="pubmed">23096096</ArticleId></ArticleIdList></Reference><Reference><Citation>Wipff J, Dieude P, Avouac J, Tiev K, Hachulla E, Granel B, et al. . Association of hypoxia-inducible factor 1A (HIF1A) gene polymorphisms with systemic sclerosis in a French European Caucasian population. Scand J Rheumatol (2009) 38(4):291&#x2013;4. doi:&#xa0;10.1080/03009740802629432</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03009740802629432</ArticleId><ArticleId IdType="pubmed">19306159</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagi K, Kawamoto M, Higuchi T, Tochimoto A, Harigai M, Kawaguchi Y. Single nucleotide polymorphisms of the HIF1A gene are associated with susceptibility to pulmonary arterial hypertension in systemic sclerosis and contribute to SSc-PAH disease severity. Int J Rheum Dis (2020) 23(5):674&#x2013;80. doi:&#xa0;10.1111/1756-185X.13822</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13822</ArticleId><ArticleId IdType="pubmed">32144871</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolosi PA, Tombetti E, Maugeri N, Rovere-Querini P, Brunelli S, Manfredi AA. Vascular remodelling and mesenchymal transition in systemic sclerosis. Stem Cells Int (2016) 2016:4636859. doi:&#xa0;10.1155/2016/4636859</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/4636859</ArticleId><ArticleId IdType="pmc">PMC4812480</ArticleId><ArticleId IdType="pubmed">27069480</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M, Soldano S, Smith V. Pathophysiology of systemic sclerosis: Current understanding and new insights. Expert Rev Clin Immunol (2019) 15(7):753&#x2013;64. doi:&#xa0;10.1080/1744666X.2019.1614915</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2019.1614915</ArticleId><ArticleId IdType="pubmed">31046487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Liu C, Lu J, Zhu L, Li M. 2-methoxyestradiol inhibits hypoxia-induced scleroderma fibroblast collagen synthesis by phosphatidylinositol 3-kinase/Akt/mTOR signalling. Rheumatology (2018) 57(9):1675&#x2013;84. doi:&#xa0;10.1093/rheumatology/key166</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/key166</ArticleId><ArticleId IdType="pubmed">29905853</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong KH, Yoo SA, Kang SS, Choi JJ, Kim WU, Cho CS. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts. Clin Exp Immunol (2006) 146(2):362&#x2013;70. doi:&#xa0;10.1111/j.1365-2249.2006.03199.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2006.03199.x</ArticleId><ArticleId IdType="pmc">PMC1942060</ArticleId><ArticleId IdType="pubmed">17034590</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu WJ, Li P, Wang L, Xu YC. Hypoxia-inducible factor-1: A potential pharmacological target to manage psoriasis. Int Immunopharmacol (2020) 86:106689. doi:&#xa0;10.1016/j.intimp.2020.106689</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.106689</ArticleId><ArticleId IdType="pubmed">32585606</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zhang G, Xiao R, Chen H, Wen H. [Expression of iNOS and HIF-1&#x3b1; with angiogenesis in affected skin biopsies from patients with psoriasis]. Zhong Nan Da Xue Xue Bao Yi Xue Ban (2010) 35(9):952&#x2013;7. doi:&#xa0;10.3969/j.issn.1672-7347.2010.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1672-7347.2010.09.009</ArticleId><ArticleId IdType="pubmed">20871160</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberger C, Solovan C, AD R, Jinping L, Treudler R, Frei U, et al. . Upregulation of hypoxia-inducible factors in normal and psoriatic skin. J Invest Dermatol (2007) 127(10):2445&#x2013;52. doi:&#xa0;10.1038/sj.jid.5700874</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.jid.5700874</ArticleId><ArticleId IdType="pubmed">17495954</ArticleId></ArticleIdList></Reference><Reference><Citation>Tovar-Castillo LE, Cancino-D&#xed;az JC, Garc&#xed;a-V&#xe1;zquez F, Cancino-G&#xf3;mez FG, Le&#xf3;n-Dorantes G, Blancas-Gonz&#xe1;lez F, et al. . Under-expression of VHL and over-expression of HDAC-1, HIF-1alpha, LL-37, and IAP-2 in affected skin biopsies of patients with psoriasis. Int J Dermatol (2007) 46(3):239&#x2013;46. doi:&#xa0;10.1111/j.1365-4632.2006.02962.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-4632.2006.02962.x</ArticleId><ArticleId IdType="pubmed">17343577</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong AW, SV V, EJ A, EN F, Rutledge JC. Angiogenesis and oxidative stress: Common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci (2011) 63(1):1&#x2013;9. doi:&#xa0;10.1016/j.jdermsci.2011.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdermsci.2011.04.007</ArticleId><ArticleId IdType="pubmed">21600738</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Su J, Li F, Chen X, Zhang G. MiR-150 regulates human keratinocyte proliferation in hypoxic conditions through targeting HIF-1&#x3b1; and VEGFA: Implications for psoriasis treatment. PloS One (2017) 12(4):e0175459. doi:&#xa0;10.1371/journal.pone.0175459</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0175459</ArticleId><ArticleId IdType="pmc">PMC5388478</ArticleId><ArticleId IdType="pubmed">28399173</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Zeng J, Yuan J, Deng X, Huang Y, Chen L, et al. . MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation. J Clin Invest (2018) 128(6):2551&#x2013;68. doi:&#xa0;10.1172/JCI97426</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI97426</ArticleId><ArticleId IdType="pmc">PMC5983326</ArticleId><ArticleId IdType="pubmed">29757188</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Br&#xfc;ck W, et al. . Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol (2003) 62(1):25&#x2013;33. doi:&#xa0;10.1093/jnen/62.1.25</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/62.1.25</ArticleId><ArticleId IdType="pubmed">12528815</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiesner D, Merdian I, Lewerenz J, Ludolph AC, Dupuis L, Witting A. Fumaric acid esters stimulate astrocytic VEGF expression through HIF-1&#x3b1; and Nrf2. PloS One (2013) 8(10):e76670. doi:&#xa0;10.1371/journal.pone.0076670</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076670</ArticleId><ArticleId IdType="pmc">PMC3789659</ArticleId><ArticleId IdType="pubmed">24098549</ArticleId></ArticleIdList></Reference><Reference><Citation>Saravani M, Rokni M, Mehrbani M, Amirkhosravi A, Faramarz S, Fatemi I, et al. . The evaluation of VEGF and HIF-1&#x3b1; gene polymorphisms and multiple sclerosis susceptibility. J Gene Med (2019) 21(12):e3132. doi:&#xa0;10.1002/jgm.3132</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgm.3132</ArticleId><ArticleId IdType="pubmed">31652374</ArticleId></ArticleIdList></Reference><Reference><Citation>Argaw AT, Zhang Y, BJ S, ML Z, Kopp N, SC L, et al. . IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol (2006) 177(8):5574&#x2013;84. doi:&#xa0;10.4049/jimmunol.177.8.5574</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.8.5574</ArticleId><ArticleId IdType="pubmed">17015745</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomoto H, Pei L, Montemurro C, Rosenberger M, Furterer A, Coppola G, et al. . Activation of the HIF1&#x3b1;/PFKFB3 stress response pathway in beta cells in type 1 diabetes. Diabetologia (2020) 63(1):149&#x2013;61. doi:&#xa0;10.1007/s00125-019-05030-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-019-05030-5</ArticleId><ArticleId IdType="pmc">PMC6945783</ArticleId><ArticleId IdType="pubmed">31720731</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankar KS, Altamentova SM, Rocheleau JV. Hypoxia induction in cultured pancreatic islets enhances endothelial cell morphology and survival while maintaining beta-cell function. PloS One (2019) 14(10):e0222424. doi:&#xa0;10.1371/journal.pone.0222424</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0222424</ArticleId><ArticleId IdType="pmc">PMC6786522</ArticleId><ArticleId IdType="pubmed">31600313</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordquist L, Friederich-Persson M, Fasching A, Liss P, Shoji K, Nangaku M, et al. . Activation of hypoxia-inducible factors prevents diabetic nephropathy. J Am Soc Nephrol (2015) 26(2):328&#x2013;38. doi:&#xa0;10.1681/ASN.2013090990</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013090990</ArticleId><ArticleId IdType="pmc">PMC4310648</ArticleId><ArticleId IdType="pubmed">25183809</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalwani A, Warren J, Liuwantara D, Hawthorne WJ, O'Connell PJ, Gonzalez FJ, et al. . &#x3b2; cell hypoxia-inducible factor-1&#x3b1; is required for the prevention of type 1 diabetes. Cell Rep (2019) 27(8):2370&#x2013;2384.e6. doi:&#xa0;10.1016/j.celrep.2019.04.086</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.04.086</ArticleId><ArticleId IdType="pmc">PMC6661122</ArticleId><ArticleId IdType="pubmed">31116982</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas DR, Tegeder I, Kuner R, Agarwal N. Hypoxia-inducible factor 1&#x3b1; protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species. J Mol Med (Berl) (2018) 96(12):1395&#x2013;405. doi:&#xa0;10.1007/s00109-018-1707-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-018-1707-9</ArticleId><ArticleId IdType="pubmed">30361814</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishan P, Singh G, Bedi O. Carbohydrate restriction ameliorates nephropathy by reducing oxidative stress and upregulating HIF-1&#x3b1; levels in type-1 diabetic rats. J Diabetes Metab Disord (2017) 19:16. doi:&#xa0;10.1186/s40200-017-0331-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40200-017-0331-5</ArticleId><ArticleId IdType="pmc">PMC5735925</ArticleId><ArticleId IdType="pubmed">29270392</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, You L, Nepovimova E, Heger Z, Wu W, Kuca K, et al. . Hypoxia-inducible factors: Master regulators of hypoxic tumor immune escape. J Hematol Oncol (2022) 15(1):77. doi:&#xa0;10.1186/s13045-022-01292-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-022-01292-6</ArticleId><ArticleId IdType="pmc">PMC9166526</ArticleId><ArticleId IdType="pubmed">35659268</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al. . mTOR- and HIF-1&#x3b1;-mediated aerobic glycolysis as metabolic basis for trained immunity. Science (2014) 345(6204):1250684. doi:&#xa0;10.1126/science.1250684</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1250684</ArticleId><ArticleId IdType="pmc">PMC4226238</ArticleId><ArticleId IdType="pubmed">25258083</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabriel SS, Kallies A. Sugars and fat - a healthy way to generate functional regulatory T cells. Eur J Immunol (2016) 46(12):2705&#x2013;9. doi:&#xa0;10.1002/eji.201646663</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201646663</ArticleId><ArticleId IdType="pubmed">27918097</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>